Department of Defense

This DoD funding supports rapid clinical trials testing new ALS treatments, from phase 1 through small phase 2 studies. Focus areas include biomarker-driven interventions and improved clinical care approaches for managing the disease.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

DoD seeks groundbreaking novel concepts to advance rare cancer research and treatment. This concept award supports highly innovative, untested ideas without requiring preliminary data, enabling early-stage exploration of potentially transformative approaches.

Air Force Commercial Solutions Opening for innovative EW, IO, and electromagnetic digital communications capabilities leveraging novel materials or services.

This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.

This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

This DoD program funds exploratory pancreatic cancer research with a patient-centered focus to develop innovative concepts and generate preliminary data for future clinical applications. Supported research should advance quality of life outcomes through robust studies that avoid preclinical animal work.

Support innovative, high-risk pancreatic cancer research ideas with potential for major breakthroughs. This award funds early-stage projects addressing key research priorities, including mentorship pathways for early-career investigators launching careers in pancreatic cancer science.

This award funds partnerships between clinicians and scientists to accelerate pancreatic cancer research from promising early-stage ideas toward clinical applications, including pilot trials and correlative studies.

DoD seeks rapid prototypes of smaller, affordable medium-range air-to-air missiles that increase weapons density in fighter and collaborative combat aircraft. The effort aims to overcome current cost and size constraints limiting firepower during contested engagements against peer threats.

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

Support innovative research into rare melanoma subtypes to advance understanding of disease mechanisms and develop targeted treatment strategies. This Army-sponsored program funds basic and translational research addressing an underexplored cancer area with significant clinical impact.

The Army seeks collaborative melanoma research teams to advance understanding and treatment of melanoma through innovative scientific approaches. This team science award supports competitive research that addresses critical gaps in melanoma biology and clinical outcomes.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.

The Army seeks melanoma research to advance understanding and treatment of this serious cancer. This Scholar Award supports innovative scientific studies that could improve patient outcomes and military medical capabilities.

This award funds translational research bridging discoveries in traumatic brain injury (TBI) and psychological health toward clinical applications. Research aims to advance understanding and treatment of TBI-related mental health conditions in military populations.

The Army seeks clinical trial research to advance traumatic brain injury and psychological health treatments for service members. This funding supports evidence-based interventions to improve diagnosis, prevention, and recovery outcomes.

This award supports health services research addressing traumatic brain injury and psychological health outcomes in military populations. It seeks evidence-based studies to improve clinical care delivery and patient outcomes for service members.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.